Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Andrew Wilson currently holds 165,000 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Andrew Wilson has been a net seller of NKTR stock. They have purchased $0 and sold $604.6K worth of shares.
Mark Andrew Wilson's most recent insider trade was on Feb 6, 2026, when they sold 165,000 shares at $0.00 per share.
Mark Andrew Wilson serves as Executive at NEKTAR THERAPEUTICS (NKTR). They have executed 30 insider transactions totaling $604.6K over their tenure at the company.
Mark Andrew Wilson holds the position of Executive at NEKTAR THERAPEUTICS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Mark Andrew Wilson has shown a selling trading pattern, with $0 in total purchases and $604.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Andrew Wilson was on Feb 3, 2021, when they sold $103.9K worth of NKTR shares. This transaction involved 5,344 shares at $19.45 per share.
Mark Andrew Wilson currently owns 165,000 shares of NEKTAR THERAPEUTICS (NKTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Andrew Wilson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Andrew Wilson has 30 Form 4 filings on record as an insider at NEKTAR THERAPEUTICS.
Set alerts for Mark Andrew Wilson and 40,000+ other insiders.